3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Recurrence
3
Neoplasm Metastasis
3
Melanoma
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Cutaneous Squamous Cell Carcinoma
2
Carcinoma, Basal Cell
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Merkel Cell
1
Breast Neoplasms
1
Advanced Non-Small Cell Lung Carcinoma
1
Adenocarcinoma
1
Interventions
Cyclophosphamide
15
romidepsin
9
Whole-Body Irradiation
9
fludarabine phosphate
8
Vincristine
8
Etoposide
8
Doxorubicin
8
Prednisone
7
Peripheral Blood Stem Cell Transplantation
7
Mycophenolic Acid
7
Brentuximab Vedotin
6
10-propargyl-10-deazaaminopterin
6
Rituximab
5
Granulocyte Colony-Stimulating Factor
5
Gemcitabine
5
Cyclosporine
5
denileukin diftitox
4
Nivolumab
4
Lenalidomide
4
mogamulizumab
3
Tacrolimus
3
Methotrexate
3
Immunohistochemistry
3
Gene Expression Profiling
3
Dexamethasone
3
Alemtuzumab
3
selinexor
2
pembrolizumab
2
pegfilgrastim
2
liposomal doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, T-Cell, Peripheral
×
cemiplimab
×
Clear all
No trials found.